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This study describes the in vitro and h vivo effect of hemin on L-alanine:qS~ioxov~e~te tr~~~~ 
activity. Hemin was shown to be an inhibitor of the purifti enzyme and this inhibition was proportional 
to the concentration of hemin, The examined kinetic data with hemin showed uncompetitive inhibition for 
both alanine and 4,khoxovalerate. An apparent Kr of 30 and 42 FM for hemin were obtained with both 
aLnine and 4,5dioxovalerate, respectively. Moreover, the enzyme activity in liver was considerably de- 
creased after the intravenous hemin administration and such an inhibition is dose and time dependent. Fur- 
thermore, maximum inhibition of the enzyme was observed 30 mm after hemm injection and 60% enzyme 
inhibition was achieved with a dose of 1.2 mg/kg body wt of rat, Thus is suggests the important role of 
this enzyme on heme biosynthesis. 
L-Almtbze:4,5-dioxovalerate transcmzinare Heme biosynthesis Hemin E&product inhibitor 
The formation of S-aminolevulinie acid (ALA), 
the first committed precursor of heme, is now con- 
sidered to be mediated by L-alanine: 4,5-dioxo- 
vaSerate transaminase (EC 2.6.1.43) in addition to 
the conventional pathway by ALA synthetase (EC 
2.3.1.37) in mammals [l-4]. The enzyme alanine: 
4,5-dioxovalerate transaminase which catalyses the 
formation of ALA via an irreversible transamina- 
tion reaction is fun~ion~ly located inside mito- 
chondria and it is more efficient than ALA syn- 
thetase pathway, isolated from the same source 
[1,5]. In addition, Okuno et al. [6] established the 
enzymatic biosynthesis of 4,%dioxovalerate by 
4-oxo-S-hydroxyvalerate dehydrogenase in rat liver 
and kidney. Furthermore, incorporation of radio- 
active 4,5-dioxovaleric acid in porphyrin and heme 
by intact respiring rat hepatocytes (71 indicates the 
* To whom corr~~~ndence should be addressed 
significant role of alanine : 4,Gdioxovalerate trans- 
aminase in heme biosynthesis. 
It is also well established that the primary site 
for regulation of the overall activity of heme 
biosynthesis in animals is at the level of ALA for- 
mation in mitochondria [8,9]. The important fact 
is that though extensive studies have been done on 
the regulatory role of ALA synthetase on heme 
biosynthesis [lo-171, nothing is yet known about 
the regulation of L-alanine : 4,Wlioxovalerate 
transaminase. Thus, to address this question, we 
examined the possible regulatory role of hemin, 
the end product of the mitochon~i~ L- 
alanine :4,Wioxovalerate transaminase pathway 
in both in vitro and in vivo rat liver. 
2. MATERIALS AND METHODS 
&Aminolevulinic acid, porphobilinogen, pro- 
toporphyrin, hemin and bilirubin were purchased 
from Sigma (St. Louis, MU). 3,5-Dibromolevu- 
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linic acid was from Porphyrin products {Logan, 
UT). 4,5Dioxovalerate was synthesized as de- 
scribed in [l]. 
2.2. Conditioning of rats 
Male Wistar rats about 60 g were fasted for 24 h 
prior to injections with free access to water. Hemin 
was dissolved as described [17] and injected into 
tail vein within 1 h after preparation. Animals 
were killed by decapitation. 
2.3. EPzzyme source 
Alanine : 4,5-dioxovalerate transaminase was 
purified to homogeneity according to our previous 
paper [3]. For mitochondrial enzyme the livers 
were homogenized in 5 vols of 20 mM potassium 
phosphate buffer, pH 7.4, containing 0.25 M 
sucrose at 4°C. Then mitochondria were isolated 
as in [ 181. The packed mitochondria were suspend- 
ed in 20 mM potassium phosphate buffer, pH 7.4, 
containing 10% glycerol, freeze-thawed, sonicated 
and centrifuged at 10000 x g for 30 min. The 
supernatant was used for the enzyme assay. 
2.4. Enzyme uss~y 
Alanine : 4,5-dioxovalerate transaminase was 
assayed as in [I]. Protein was determined by the 
method in [19]. 
3. RESULTS AND DISCUSSION 
3. I. Effect of some intermediate compounds of 
heme metubolism on purified i&nine:4,5- 
dioxov~lerQte trans~minase 
This study has been undertaken to determine the 
effect of some of the intermediate compounds of 
heme metabolism on purified alanine :4,5-dioxo- 
valerate transaminase (table 1). Appropriate con- 
trol reactions were carried out simultaneously. Our 
findings clearly indicate that none of these com- 
pounds have any significant effect on purified 
alanine :4,%dioxovalerate transaminase activity. 
3.2. Inhibition of purified alanine:4,5- 
dioxovaie~~te ransaminase by hemin 
Several experiments were carried out in which 
effect of hemin was studied on the activity of 
alanine :4,5-dioxovalerate transaminase. As shown 
in fig. 1, hemin inhibited the purified enzyme and 
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Table 1 
Effect of some intermediary compounds of heme 
metabolism on the activity of alanine: 4,5-dioxovalerate 
transaminasea 
Metabolite Concentration Specific activity 
WW (urn01 ALA 
formed/mg 
protein per 
30 min) 
- 13.36 
Aminolevu~inic acid 50 12.70 ( 5) 
100 12.41 ( 7) 
200 12.33 ( 7) 
Porphobilinogen 50 13.19 ( 1) 
100 13.00 ( 3) 
200 12.82 ( 4) 
Protoporphyrin 50 12.80 ( 4) 
100 12.14 ( 9) 
200 11.37 (15) 
Bihrubin 50 13.36 ( 0) 
100 il.82 (12) 
200 10.94 (22) 
a The purified enzyme was first preincubated for 5 min 
at 37°C with the metabolites. The treated fractions 
were immediately diluted with the assay substrates. 
The conditions were the same as mentioned in section 2 
Numbers in parentheses indicate % inhibition 
such inhibition was greater at higher concentra- 
tions of hemin. An inhibition of 20% was observed 
with the addition of 5 PM hemin whereas 50010 in- 
hibition was obtained with 50/1M of hemin 
addition. 
When ALA formation was measured as a func- 
tion of alanine or 4,5-dioxovalerate concentrations 
in the presence of hemin at either 0.05 or 0.1 mM, 
parallel lines typical of uncompetitive inhibition 
for both the substrates were generated (fig.ta,b). 
Hemin for alanine :4,5-dioxovalerate transaminase 
exhibited a Ki of 30pM with different concentra- 
tions of alanine, at fixed 4,5-dioxovalerate concen- 
tration. However, when 4,5-dioxovalerate concen- 
tration was varied, at fixed alanine concentration, 
the Kr was 42 FM. It is evident from our studies 
that only hemin among the other intermediate 
metabolites acts as inhibitor of this enzyme. 
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Fig. 1. Inhibition of purified alanine : 4,~-dioxov~erate 
transaminase activity by exogenous hemin. The enzyme 
was preincubated with different concentrations of hemin 
for 5 min and was assayed. 
3.3. Effect of ~emin admi~~trat~~n on the uctivity 
of L-alanine:4,5-dioxovaierate transaminase 
in rat liver mitochondria 
To examine whether the observed regulatory ac- 
tion of hemin really has any physiological 
significance in normal rats, the effect of hemin ad- 
ministration on the activity of alanine :4,5-dioxo- 
valerate transaminase has been studied. Hemin at 
.0.8 mg/kg body wt was administered intravenous- 
ly to rats and the time course study was carried out 
up to 2 h (fig.3). The activity of the enzyme de- 
creased rapidly and the maximum inhibition of 
42% was observed after 30 min. Fu~hermore, 
when rats were given various doses of hemin injec- 
tions the enzyme activity decreased progressively 
with the increasing hemin doses (fig.4) and such in- 
hibition appeared to be nearly maximal at a hemin 
dose of 1.2 mg/kg body wt. 
This is the first report which shows in vitro and 
in vivo inhibition of alanine :4,5dioxovalerate 
transaminase by hemin, the end product, sug- 
gesting the regulatory role of this enzyme on heme 
biosynthesis. It is important to mention the 
previous findings [20,21] that the administration 
of hemin resulted in a rapid decline of ALA in 
serum. Therefore, the inhibition of 
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Fig.2. Hemin as an end product inhibitor: (a) plot of l/v 
against l/(~anine),(dioxov~erate) = 0.2 mM. (b) Plot 
of l/v against l/(~oxov~erate),(al~ine) = 20 mM. 
alanine :4&dioxovalerate transaminase by heme, 
which is synthesized intramitochondrially [22], 
may be a potential regulatory factor for heme 
biosynthesis by means of feedback inhibition. 
Moreover, generation of heme in mitochondrial 
preparations [23] at least 75times the basal rate 
occurring in vivo does not change the ALA syn- 
thetase activity and it was concluded that end pro- 
duct inhibition of ALA synthetase activity by heme 
is not an important physiological mechanism for 
regulation of hepatic heme biosynthesis. Thus, 
considering the above reports it may be reasonable 
to assume that inhibition of alanine:4,5_dioxo- 
131 
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Fig.3. Effect of hemin administration on L- 
alanine: 4,5-dioxovalerate transaminase activity in rat 
liver mitochondria. Rats were given (0.8 mg/kg body 
wt) injections intravenously and were killed for enzyme 
assay at the times indicated. Each point represents the 
value obtained for pooled livers of 6 rats. 
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Fig.4. Effect of hemin administration on L- 
alanine : 4,5-dioxovalerate transaminase activity in rat 
liver mitochondria. Rats were given indicated doses of 
hemin intravenously and sacrificed 30 min later for 
enzyme assay. Other conditions are as described for 
fig.3. 
valerate transaminase by heme is an important 
physiological mechanism for regulation of hepatic 
heme biosynthesis. 
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